Physician profile
Fernando Porter
NPI 1669785770
$2,290.66
in general payments reported to CMS, 2019-2025
13 companies · $459 in 2025
The $459 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.93 · 2020: $48.09 · 2021: $266 · 2022: $582 · 2023: $520 · 2024: $317 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,295.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $945.46 | 2021-2025 | Biktarvy |
| Viiv Healthcare Company | $369.97 | 2021-2025 | Dovato |
| Lilly USA, LLC | $245.22 | 2020-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $230.26 | 2022-2025 | Ozempic, Rybelsus |
| Amgen INC. | $152.27 | 2019-2022 | |
| Exact Sciences Corporation | $99.35 | 2023-2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $72.43 | 2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $68.56 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.09 | 2022 | |
| Boston Scientific Corporation | $29.21 | 2023 | Bodyguardian |
| Abbvie INC. | $26.94 | 2021 | |
| Genentech USA, INC. | $19.90 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.